000			01336 a2200349 4500
005			20250512010035.0
264		0	_c19901116
008			199011s 0 0 eng d
022			_a0927-3042
024	7		_a10.1007/978-1-4613-1595-7_8 _2doi
040			_aNLM _beng _cNLM
100	1		_aNanus, D M
245	0	0	_aSystemic chemotherapy in the management of bladder cancer. _h[electronic resource]
260			_bCancer treatment and research _c1989
300			_a143-58 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.; Review
650	0	4	_aAntineoplastic Agents _xtherapeutic use
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use
650	0	4	_aCisplatin _xtherapeutic use
650	0	4	_aClinical Trials as Topic
650	0	4	_aCombined Modality Therapy
650	0	4	_aDoxorubicin _xtherapeutic use
650	0	4	_aDrug Evaluation
650	0	4	_aHumans
650	0	4	_aMethotrexate _xtherapeutic use
650	0	4	_aRecurrence
650	0	4	_aUrinary Bladder Neoplasms _xdrug therapy
650	0	4	_aVinblastine _xtherapeutic use
700	1		_aBosl, G J
773	0		_tCancer treatment and research _gvol. 46 _gp. 143-58
856	4	0	_uhttps://doi.org/10.1007/978-1-4613-1595-7_8 _zAvailable from publisher's website
999			_c2583128 _d2583128